Labcorp Holdings Inc. (LH) Return on Invested Capital (ROIC): 7.39%
Is Labcorp Holdings Inc.’s return on invested capital (ROIC) high or low?
Labcorp Holdings Inc.'s return on invested capital (ROIC) of 7.39% is in line with its 5-year average of 7.56%, around the middle of its 5-year range (3.31%–13.03%).
As of Sunday, June 14, 2026. 17.30% above its 12-month average of 6.30%.
LH Return on Invested Capital (ROIC) Chart
LH Average Return on Invested Capital (ROIC) Chart
LH Current vs Average Return on Invested Capital (ROIC) Chart
LH Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
7.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
6.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
5.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
8.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
8.96%
CURRENT VS TTM AVG
+17.30%
CURRENT VS 3Y AVG
+31.09%
CURRENT VS 5Y AVG
-2.23%
CURRENT VS 10Y AVG
+3.49%
CURRENT VS 15Y AVG
-8.13%
CURRENT VS 20Y AVG
-17.53%
LH Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 7.39% | 6.30% | 5.64% | 7.56% |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 35.46% | 38.26% | 37.51% | 36.01% |
| BioNTech SE (BNTX) | $22.90B | -3.14% | -4.79% | 9.55% | 20.42% |
| United Therapeutics Corporation (UTHR) | $23.17B | 16.14% | 15.79% | 14.57% | 13.09% |
| Waters Corporation (WAT) | $23.17B | 17.57% | 18.00% | 20.73% | 22.79% |
| Moderna, Inc. (MRNA) | $19.80B | -29.70% | -31.12% | -12.69% | 0.19% |
| Veeva Systems Inc. (VEEV) | $25.92B | 9.48% | 9.25% | 9.54% | 11.31% |
| Hologic, Inc. (HOLX) | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| DexCom, Inc. (DXCM) | $29.08B | 16.61% | 13.40% | 11.07% | 9.62% |
| Biogen Inc. (BIIB) | $29.53B | 6.62% | 7.71% | 8.64% | 10.90% |
Capital Efficiency
ROIC
7.4%
ROE
10.8%
Labcorp Holdings Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The return on invested capital (ROIC) for LH stock is 7.39%.
- Is Labcorp Holdings Inc.'s return on invested capital (ROIC) high or low?
- Labcorp Holdings Inc.'s return on invested capital (ROIC) of 7.39% is in line with its 5-year average of 7.56%, around the middle of its 5-year range (3.31%–13.03%).
- What is the TTM average return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The TTM average return on invested capital (ROIC) for LH stock is 6.30%.
- What is the 3Y average return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The 3Y average return on invested capital (ROIC) for LH stock is 5.64%.
- What is the 5Y average return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The 5Y average return on invested capital (ROIC) for LH stock is 7.56%.
- What is the 10Y average return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The 10Y average return on invested capital (ROIC) for LH stock is 7.14%.
- What is the 15Y average return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The 15Y average return on invested capital (ROIC) for LH stock is 8.04%.
- What is the 20Y average return on invested capital (ROIC) for Labcorp Holdings Inc. (LH)?
- The 20Y average return on invested capital (ROIC) for LH stock is 8.96%.
Labcorp Holdings Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 7.39% |
| 2024-12-31 | 5.21% |
| 2023-12-31 | 3.31% |
| 2022-12-31 | 6.64% |
| 2021-12-31 | 13.03% |
| 2020-12-31 | 9.77% |
| 2019-12-31 | 6.21% |
| 2018-12-31 | 6.45% |
| 2017-12-31 | 9.22% |
| 2016-12-31 | 6.71% |
| 2015-12-31 | 4.61% |
| 2014-12-31 | 8.46% |
| 2013-12-31 | 9.85% |
| 2012-12-31 | 10.12% |
| 2011-12-31 | 10.47% |
| 2010-12-31 | 11.26% |
| 2009-12-31 | 13.87% |
| 2008-12-31 | 11.95% |
| 2007-12-31 | 11.57% |
| 2006-12-31 | 11.52% |
| 2005-12-31 | 10.55% |
| 2004-12-31 | 10.70% |
| 2003-12-31 | 9.97% |
| 2002-12-31 | 10.74% |
| 2001-12-31 | 11.69% |
| 2000-12-31 | 9.08% |
| 1999-12-31 | 6.45% |
| 1998-12-31 | 7.37% |
| 1997-12-31 | -4.17% |
| 1996-12-31 | -4.64% |
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter